Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "SEC"

2504 News Found

India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData
News | August 25, 2023

India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData

India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023


Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ
News | August 24, 2023

Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ

The company has entered into a three-year Deferred Prosecution Agreement


First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
Policy | August 24, 2023

First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl

Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl


Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation
News | August 24, 2023

Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation

Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country


Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets
News | August 23, 2023

Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets

Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive


Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
News | August 23, 2023

Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round

Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO


Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
News | August 22, 2023

Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment


ABB India bags automation order for Reliance Life Sciences' biopharmaceutical facilities
Digitisation | August 21, 2023

ABB India bags automation order for Reliance Life Sciences' biopharmaceutical facilities

ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra


EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
Drug Approval | August 21, 2023

EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema

LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment


Venus Remedies launches its flagship R&D drug Elores in Oman
News | August 21, 2023

Venus Remedies launches its flagship R&D drug Elores in Oman

The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025